Skopeion™
A Next-Generation Biosensor for Cancer Cell Detection
Early detection changes outcomes.
Skopeion is our proprietary biosensor platform designed to detect free cancer cells and tumor-associated biomarkers with exceptional sensitivity.
What Skopeion Does
- Detects circulating cancer cells and related biological signatures
- Enables earlier intervention and monitoring
- Supports longitudinal cancer surveillance
Skopeion is designed to function as a high-precision biological sensing platform, integrating nanotechnology, advanced materials, and computational interpretation.
SKOPEION™
The Technology Behind Skopeion
Skopeion is built using state-of-the-art nanotechnology and biological surface engineering, optimized for interaction at the cellular and molecular level.
Key characteristics include:
- Nanoscale detection architectures
- High signal-to-noise biological interfaces
- Advanced pattern recognition for cellular differentiation
- Compatibility with future clinical workflows
Rather than relying on a single marker, Skopeion is designed to recognize complex biological signatures, improving robustness across cancer subtypes.
Why Biosensors Matter in Oncology
Cancer is dynamic. Detection should be as well.
Biosensors enable:
- Earlier diagnosis
- Monitoring of disease progression
- Evaluation of treatment response
- Detection of recurrence
Skopeion is designed to support continuous, minimally invasive insight into cancer biology.
Therapeutic Discovery Pipeline
Molecular Therapeutics
In parallel with diagnostics, Strandwise is advancing molecular therapeutics discovered through autonomous scientific reasoning and simulation.
Our current pipeline includes two novel molecular candidates under development for gastrointestinal cancers.
Focus on Gastrointestinal Oncology
We are initially concentrating on:
- Pancreatic Cancer
- Colorectal Cancer
- Gastric Cancer
These cancers were selected deliberately due to:
- High mortality rates
- Late detection challenges
- Limited therapeutic options
- Complex biological mechanisms
They represent areas where improved detection and novel therapies can have immediate impact.
Molecular Discovery Approach
Our molecular candidates are generated through a discovery process that integrates:
- Continuous analysis of global oncology research
- Mechanism-driven hypothesis generation
- Advanced molecular simulation
- Iterative refinement based on biological constraints
This approach allows us to explore non-obvious molecular spaces and identify candidates aligned with real biological mechanisms.
From Discovery to Translation
Strandwise research is designed with translation in mind.
Our programs emphasize:
- Biological plausibility
- Clear mechanism of action hypotheses
- Traceable discovery lineage
- Compatibility with regulatory pathways
We believe the most valuable discoveries are those that can move efficiently from insight to impact.
An Integrated Research Ecosystem
What makes Strandwise unique is the integration of our research efforts.
Diagnostics inform therapeutics.
Therapeutics inform diagnostics.
Discovery is continuous, not siloed.
This integrated model allows us to:
- Refine detection strategies based on therapeutic insights
- Identify biomarkers relevant to both diagnosis and treatment
- Adapt research focus as new evidence emerges
Looking Ahead
Our research roadmap includes:
- Expansion of the Skopeion biosensor platform
- Advancement of gastrointestinal cancer therapeutics
- Exploration of additional oncology indications
- Deeper integration between diagnostics and treatment
All guided by autonomous scientific intelligence and grounded in biological reality.
